丁吡考胺
丁吡考胺 | |
---|---|
![]() | |
IUPAC名 5-Butylpyridine-2-carboxamide | |
別名 | Sch-10595; Fusaramide[1] |
識別 | |
CAS號 | 22632-06-0 ![]() |
PubChem | 31447 |
ChemSpider | 29167 |
SMILES |
|
InChI |
|
InChIKey | VKSPIPWLHGKJQO-UHFFFAOYAT |
性質 | |
化學式 | C10H14N2O |
摩爾質量 | 178.23 g·mol−1 |
若非註明,所有數據均出自標準狀態(25 ℃,100 kPa)下。 |
丁吡考胺(英語:Bupicomide,化學名:5-丁基吡啶-2-酰胺,5-Butylpyridine-2-carboxamide)是一種有機化合物,化學式C10H12N2O,具有β受體阻滯劑功能,在臨床上用於血管舒張。[2][3][4]
參考文獻
- ^ Bupicomide (頁面存檔備份,存於網際網路檔案館), Chemical Book
- ^ Chrysant, SG; Adamopoulos, P; Tsuchiya, M; Frohlich, ED. Systemic and renal hemodynamic effects of bupicomide: A new vasodilator. American Heart Journal. 1976, 92 (3): 335–9. PMID 782220. doi:10.1016/s0002-8703(76)80114-7.
- ^ Velasco, M; Gilbert, CA; Rutledge, CO; McNay, JL. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: A comparison with hydralazine. Clinical Pharmacology and Therapeutics. 1975, 18 (2): 145–53. PMID 1097150. S2CID 19966617. doi:10.1002/cpt1975182145.
- ^ Velasco, M.; McNay, J. L. Physiologic mechanisms of bupicomide- and hydralazine-induced increase in plasma renin activity in hypertensive patients.. Mayo Clinic Proceedings. 1977, 52 (7): 430–2. PMID 875465.